Company
Karyopharm Therapeutics Inc.
KPTI · CIK 0001503802
Sale of 4,788 shares at $0.344 per share.
Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001193125-26-425227 · filed 2026-10-19 · View filing →
Sale of 378 shares at $1.19 per share.
Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001193125-26-412209 · filed 2026-10-02 · View filing →
Sale of 19 shares at $2.02 per share.
Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-380404 · filed 2026-09-02 · View filing →